Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells
Open Access
- 13 July 2017
- journal article
- Published by American Society of Hematology in Blood
- Vol. 130 (2) , 176-180
Abstract
Key Points: BRAF V600E mutations are detectable in hematopoietic stem and progenitors in adults with histiocytosis. Transplantation of CD34+ cells from histiocytosis patients can give rise to genetically and phenotypically accurate xenografts.Keywords
This publication has 26 references indexed in Scilit:
- High prevalence of somatic MAP2K1 mutations in BRAF V600E–negative Langerhans cell histiocytosisBlood, 2014
- Femoral Bone Marrow Aspiration in Live MiceJournal of Visualized Experiments, 2014
- Somatic activating ARAF mutations in Langerhans cell histiocytosisBlood, 2014
- BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groupsJournal of Experimental Medicine, 2014
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutationBlood, 2013
- High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytosesBlood, 2012
- TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human LymphomagenesisCancer Cell, 2011
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3Leukemia, 2010
- Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans CellsThe Journal of Immunology, 2010